0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer

G. M. Thomas; S. Ali; M. Patel; O. Abulafia; J. A. Lucci

doi:10.1136/ijgc-00009577-200610001-00017

Article info

ABSTRACT: Free Communications: Cervical Cancer - Sunday, October 15, 2006

0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer

Authors

G. M. Thomas Radiation Oncology, Toronto Sunnybrook Cancer Center, Toronto, Canada PubMed articles Google scholar articles
S. Ali GOG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, USA PubMed articles Google scholar articles
M. Patel Radiation Oncology, JCC at Hamilton Health Science, Hamilton, USA PubMed articles Google scholar articles
O. Abulafia Department of Gynecologic Oncology, SUNY Health Science Center, Brooklyn, USA PubMed articles Google scholar articles
III J. A. Lucci Gynecologic Oncology, Galveston, USA PubMed articles Google scholar articles

Citation

Thomas GM, Ali S, Patel M, et al

0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer

International Journal of Gynecologic Cancer 2006;16:603-604.

Online issue publication

December 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password